Niagen Bioscience (NAGE)

• Market cap: $264M
• 1 day: 3.11%
• 5 days: 3.75%
• 1 month: 4.08%
• 3 months: -29.81%
• 6 months: -44.57%
• Year to date: -46.88%
• 1 year: -65.16%
• 5 years: -61.8%
• 10 years: -14.43%
• Sector: Healthcare
• Industry: Biotechnology

About: Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

Employees: 117